Motus GI Holdings, Inc. (MOTS)
| Market Cap | 34.61M |
| Revenue (ttm) | 220,000 |
| Net Income (ttm) | -23.87M |
| Shares Out | 47.73M |
| EPS (ttm) | -0.59 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 157,997 |
| Open | 0.705 |
| Previous Close | 0.705 |
| Day's Range | 0.703 - 0.722 |
| 52-Week Range | 0.674 - 2.740 |
| Beta | 2.58 |
| Analysts | Buy |
| Price Target | 2.03 (+183.0%) |
| Est. Earnings Date | Nov 11, 2021 |
About MOTS
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Financial Performance
In 2020, MOTS's revenue was $98,000, a decrease of -8.41% compared to the previous year's $107,000. Losses were -$19.26 million, -16.59% less than in 2019.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 2.03, which is an increase of 182.97% from the latest price.
News
Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System
FORT LAUDERDALE, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Holdings, Inc. (MOTS) Reports Q2 Loss, Tops Revenue Estimates
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.09% and 20.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Motus GI to Release Second Quarter Results and Provide a Business Update on August 12
FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
Motus GI to Present at the Ladenburg Thalmann Healthcare Conference
FORT LAUDERDALE, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...
Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Au...
FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
Motus GI's Pure-Vu System® Adopted by Sinai Hospital of Baltimore
Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of ...
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Tops Revenue Estimates
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -10.00% and 27.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Motus GI Hldgs Q1 Earnings
Shares of Motus GI Hldgs (NASDAQ:MOTS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 52.17% year over year to ($0.11), which missed t...
Motus GI Reports First Quarter 2021 Financial Results and Provides Corporate Update
FORT LAUDERDALE, Fla., May 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cli...
Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness ...
- - - - The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveil...
Motus GI Holdings, Inc. (MOTS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOTS Stock: The Big FDA News That Has Motus GI Holdings Soaring Today
Motus GI Holdings (MOTS) stock is on the rise Friday following clearance from the FDA for one of the company's medical devices. The post MOTS Stock: The Big FDA News That Has Motus GI Holdings Soaring T...
Penny Stocks to Buy? Check These Tech Stocks Out
Tech penny stocks are back in focus; check these 3 out The post Penny Stocks to Buy? Check These Tech Stocks Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Motus GI Receives FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy
FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy
Motus GI Holdings Inc (NASDAQ: MOTS) has submitted a 510(k) application to the FDA for a version of the Pure-Vu System. The new version of the system is compatible with gastroscopes used during upper ga...
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0.00% and -61.29%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
FORT LAUDERDALE, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleed...
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI to Participate in Two Upcoming Investor Conferences in March 2021
FORT LAUDERDALE, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve c...
Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million
FORT LAUDERDALE, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...